31/08/2023  21:59:59 Var. -0.9100 Volume Denaro01:50:00 Lettera01:50:00 Capitalizzazione di mercato Dividend Y. Rapporto P/E
39.7500USD -2.24% 31.37 mill.
Fatturato: 336.35 mill.
39.2900Quantità in denaro: - 39.9000Quantità in lettera: - 2.08 bill.USD - 50.96

Descrizione business

NuVasive is a global medical device company focused on transforming spine surgery by empowering surgeons with technology to approach procedures in the least disruptive way possible and restore the vitality of life for those that suffer from debilitating spinal conditions. Through its minimally invasive, procedurally-integrated solutions, the Company is expanding the boundaries of modern healthcare with technologies and surgeon training designed to provide reproducible and clinically-proven surgical outcomes that are redefining the success factors of spine surgery like never before. Addressing a variety of pathologies up and down the spine, from complex spinal deformity to degenerative spinal conditions, NuVasive's highly differentiated solutions include access instruments, implantable hardware and increasingly expert software systems like its game-changing iGA™ surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. NuVasive believes its integrated approach and expertise can fundamentally evolve spine care by delivering improved patient experiences, and better economics for healthcare systems.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
J. Christopher Barry
Consiglio di amministrazione
Matthew K. Harbaugh, Aviva McPherron, Brent Boucher, Dale Wolf, Kyle Malone, Lucas Vitale, Massimo Calafiore, Michael Farrington, Nathaniel Sisitsky, Sean Freeman
Consiglio di sorveglianza
Daniel J. Wolterman, Amy Belt Raimundo, Donald J. Rosenberg, J. Christopher Barry, John A. DeFord, Leslie V. Norwalk, R. Scott Huennekens, Robert F. Friel, Siddhartha Kadia, Vickie L. Capps
 

Dati aziendali

Name: NuVasive Inc.
Indirizzo: 7475 Lusk Boulevard,San Diego, California 92121, USA
Telefono: +1-858-909-1800
Fax: +1-800-475-9134
E-mail: info@nuvasive.com
Internet: www.nuvasive.com/
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 31/12
Flottante libero: 60.20%
Data dell'IPO: -

Rapporti con gli investitori

Name: Juliet C. Cunningham
IR telefono: +1-858-458-2240
IR Fax: -
IR e-mail: investorrelations@nuvasive.com

Principali azionisti

Freefloat
 
60.20%
Wellington Management Company LLP
 
13.00%
BlackRock, Inc.
 
12.20%
The Vanguard Group
 
9.40%
The Hartford Mutual Funds, Inc.
 
5.20%